Tirzepatide (Mounjaro) has rapidly become one of the most discussed medications in diabetes and obesity medicine. Its dual GIP/GLP-1 receptor agonist mechanism produces unprecedented reductions in blood sugar and body weight. But what does the evidence say about its cardiovascular effects — and how does it compare to semaglutide? How Tirzepatide Works Unlike semaglutide, which…
Category: Type 2 diabetes
When Should Someone with Diabetes See a Cardiologist?
Diabetes significantly increases cardiovascular risk, yet many people with diabetes never see a cardiologist — even when they should. Knowing when to ask for a cardiology referral, and what to expect when you get one, could be one of the most important steps you take for your long-term health. Why People with Diabetes Have Elevated…
Statins and Diabetes: Understanding the Risks, Benefits, and the Latest Evidence
Statins are among the most prescribed medications in the world, and for people with diabetes, they are a cornerstone of cardiovascular risk reduction. Yet they are also among the most misunderstood — surrounded by myths about muscle damage, memory loss, and a supposed link to worsening diabetes. This guide cuts through the noise with evidence-based…
CGM Patterns That Predict Cardiovascular Risk: What Your Glucose Data Is Telling You
Your continuous glucose monitor does far more than track your blood sugar in real time. The patterns it reveals — the peaks, troughs, and variability between readings — are increasingly recognised as powerful predictors of cardiovascular risk. Understanding what your CGM data is telling you about your heart health could be one of the most…
5 Salmon Recipes That Are Perfect for Your Heart and Blood Sugar
Salmon is one of the most nutritionally valuable foods for people with diabetes and cardiovascular risk. Rich in EPA and DHA omega-3 fatty acids, high-quality protein, and vitamin D, it simultaneously lowers triglycerides, reduces inflammation, supports blood pressure management, and has minimal impact on blood glucose. These five recipes make it easy to enjoy salmon…
Aspirin and Diabetes: What the Current Guidelines Actually Say
For decades, low-dose aspirin was routinely recommended for people with diabetes as a cardiovascular preventive measure. Recent large-scale trials have fundamentally changed this approach. The current evidence suggests that aspirin’s benefits in diabetes are far more limited than previously believed — and its risks more significant. Here is what the latest guidelines actually say. How…
Walking for Heart Health with Diabetes: A 4-Week Programme
Walking is the most accessible, evidence-based exercise for people with diabetes. It requires no equipment, no gym membership, and no special fitness level. Yet its cardiovascular and metabolic benefits are profound: regular brisk walking reduces HbA1c, lowers blood pressure, improves cholesterol, aids weight management, and reduces the risk of major cardiovascular events by up to…
Diabetes and Intimacy: The Honest Conversation Nobody Has
Sexual health is an integral component of overall wellbeing, yet it remains one of the most under-discussed topics in diabetes care. Both men and women with diabetes experience a significantly higher prevalence of sexual dysfunction than the general population — a consequence of the vascular, neurological, and psychological effects of the condition. Breaking the silence…
Love Your Heart: The Essential Cardiovascular Health Check Checklist for Diabetes
February is Heart Health Month — the perfect time to take stock of your cardiovascular health. For people with diabetes, proactive cardiovascular screening is not optional; it is a clinical necessity. This checklist covers everything you should be monitoring and discussing with your healthcare team to protect your heart. Your Annual Cardiovascular Health Checklist Test…
How CGM Data Can Reveal Your Cardiovascular Risk
Continuous glucose monitoring (CGM) has transformed diabetes management by providing real-time glucose data that finger-prick testing cannot match. Beyond its immediate utility for dosing decisions, emerging research suggests that CGM-derived metrics — particularly glucose variability — may be powerful predictors of cardiovascular risk, offering insights that HbA1c alone cannot provide. Beyond HbA1c: Why Glucose Variability…










